Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review
journal contribution
submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:19 authored by Elabbass A. Abdelmahmuod, Abdelrahman Hamad, Ahmed Almaghraby, Samah Mohamed, Maryam AlkuwariThe probability of right heart thrombus co-existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The prevention and management of intracardiac thrombotic events include early use of anticoagulation therapy.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: http://dx.doi.org/10.1002/ccr3.4137
History
Language
- English
Publisher
WileyPublication Year
- 2021
Institution affiliated with
- Hamad Medical Corporation
